Clinical Trials
25 trialsNCT00004070 2017-04-20
Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT00004893 2016-07-19
Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00003210 2015-04-15
Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003107 2014-09-10
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Indiana University
Phase 1 Completed
NCT00003339 2014-05-22
Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
University of Southern California
Phase 2 Completed
NCT00031733 2014-05-22
Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
University of Southern California
Phase 2 Completed
NCT00015977 2014-03-07
Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
University of Chicago
Phase 2 Completed
NCT00002952 2013-09-05
Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma
University of Chicago
Phase 1/2 Completed
NCT00026182 2013-08-26
Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003017 2013-06-21
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003149 2013-06-21
Interleukin-12 in Treating Patients With Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00020449 2013-06-19
Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00026143 2013-06-05
Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00028535 2013-06-04
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004244 2013-03-21
Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004074 2013-02-28
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003330 2013-02-11
Interleukin-12 in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003575 2013-02-08
Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003439 2013-02-07
Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003451 2013-02-01
Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005604 2013-02-01
Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00016289 2013-01-23
Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00899821 2012-11-09
Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer
NYU Langone Health
Phase NA Completed
NCT00003046 2012-07-30
Interleukin-12 in Treating Patients With Cancer in the Abdomen
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00004260 2011-08-03
Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Mayo Clinic
Phase 1 Completed